increased platelet activation has been suggested as a possible reason for t
he increased vulnerability of depressed patients to ischemic heart disease
(IHD). Translocation of p-selectin, an integral alpha -granule membrane pro
tein, to the platelet surface is a measure of platelet activation. Herein,
western blots of platelet plasma membranes containing p-selectin were quant
ified in patients with major depression (it = 19: mean age = 39 +/- 2 years
) and healthy comparison subjects (n = 17; mean age = 36 +/- 2 years). None
evidenced clinical signs of IHD, and only two patients had a lifestyle IHD
risk factor (smoking), Blood was obtained from all 19 depressed patients b
efore treatment, and 15 returned after 6-8 weeks of open-label bupropion tr
eatment. Bupropion was chosen as the antidepressant because it did not elev
ate plasma norepinephrine or serotonin, endogenous agonists that can induce
platelet degranulation. Western blotting revealed more p-selectin immunore
activity (75 kD band) in depressed patients compared to healthy controls (P
= 0.003). After bupropion treatment, p-selectin remained high in depressed
patients. beta3-Integrin; a reference plasma membrane protein that does no
t translocate during activation, was of equivalent density in depressed pat
ients and healthy control subjects, and was unchanged after treatment with
bupropion. p-Selectin failed to correlate with severity of illness based on
the Hamilton Depression scale, or with the post-treatment plasma concentra
tion of bupropion. The results suggest an elevation in p-selectin on platel
et plasma membranes might be a trait marker for depression. (C) 2001 Elsevi
er Science Ltd. All rights reserved.